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Purpose: Dual specificity phosphatases (DUSPs) modulate the duration and magnitude of phospho-activation of Erk1/2,
p38 and JNK1/2, the terminal kinases (TKs) of the mitogen activated protein kinase  (MAPK) cascades. Three DUSPs,
DUSP1, DUSP5, and DUSP6, are overexpressed in ocular surface side population stem cells (SPSCs). Our objective was
to identify the impact of these enzymes on TK phosphorylation and proliferation of corneal epithelial cells.
Methods: SV40 immortalized (sv) and expanded fresh human corneal epithelial cells (efHCECs) were transduced with
lentivectors to elicit expression of shRNAmir against DUSP1, DUSP5, and JNK1 to thereby create the DUSP1i, DUSP5i
and JNKi cell sublines, or overexpress DUSP6 (henceforth DUSP6+), respectively. TK phosphorylation status and
proliferation rates were determined by immunoblotting and 3H thymidine uptake.
Results: In both ef and svHCECs, EGF supplementation after a 24 h serum starvation caused a rapid 5–15 min spike in
the phosphorylation of all three TK types. This was followed by gradual decreases to low phosphorylation levels within
one h. These declines coincided with dramatic increases in DUSP1 and DUSP5 protein expression. In DUSP1i, the DUSP1
increase was abolished. All 3 TKs maintained high phosphorylation levels for at least 90 min and proliferation rates were
unchanged  from  non-transduced  cells.  In  DUSP5i,  the  DUSP5  protein  increase  was  prevented,  the  post  peak
phosphorylation decrease occurred only on Erk1/2 and the proliferation rate increased by 50%–60%. In JNK1i, JNK1 was
essentially knocked out and proliferation rates were also markedly elevated. At steady-state, DUSP1i maintained high
levels of pJNK1/2 expression. In DUSP6+ Erk1/2 phosphorylation was prevented and proliferation rates decreased to less
than 50%.
Conclusions: DUSP5 and DUSP6 selectively control ERK pathway activity and proliferation. The lack of an effect of
DUSP1 knockdown on proliferation can be attributed to its pan-MAPK effect. The expected augmented proliferative
response due to enhanced and prolonged phosphorylation of Erk1/2 following DUSP1 knockdown does not occur because
a pJNK1/2 antiproliferative effect is simultaneously unleashed.
Mitogen activated protein kinase (MAPK) cassettes are
a super family composed of signaling pathways that transduce
different extracellular signals to elicit a host of cell specific
responses. Erk1/2, p38 and JNK1/2 are terminal kinases (TKs)
in these pathways. These enzymes phosphorylate numerous
substrates,  including  cytosolic  and  nuclear  transcription
factors [1-4]. Nuclear transcription factor activation occurs as
consequence of rapid TK translocation from the cytoplasm to
the nucleus [5-7]. The Erk1/2 pathway is intimately associated
with the control of growth factor activated cell proliferation
primarily as a result of its effect on transcription factors that
facilitate the G1 to S cell cycle step [5]. The phosphorylation
of the TKs is modulated by a family of TK-targeting (typical)
dual  specificity  phosphatases  (DUSPs).  DUSPs  can
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simultaneously dephosphorylate MAPK serine and tyrosine
residues. There are 10 typical DUSPs enzymes designated
DUSP1, DUSP3 through DUSP10, and DUSP16 [8-10]. Each
one of these enzymes displays distinct features in their MAPK
specificity, cellular localization and responsiveness to cellular
activation. DUSP5 is a vaccinia virus-related, Erk1/2-specific
inducible nuclear enzyme that is rapidly induced following
MAPK activation [11], DUSP1, while nuclear and inducible,
shows a pan-MAPK activity spectrum [12] and DUSP6 while
substantially selective for Erk1/2, has a cytosolic location
[13]. Many of the reported features of the DUSPs are based
on results obtained in vitro in which purified DUSPs were
used to characterize their specific interactions with MAPKs.
In  practice,  expression  profiles,  compartmentalization,
responsiveness  to  cellular  activation  and  MAPK-DUSP
stoichiometry may all contribute to the modulation of MAPK
controlled  activities  in  each  particular  cell  lineage  or
condition.
We have recently shown that ocular surface epithelial
stem  cells  (SPSC)  possessing  the  quiescent,  slow  cycling
phenotype [14-16], display high constitutive expression levels
of several typical DUSPs, including DUSP1, DUSP5, and
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1696DUSP6 [17,18]. Given the aforementioned DUSP features,
we proposed that this overexpression contributes to the slow
cycling features of adult SPSC [17,18]. In this report, using
lentiviral transduction methodologies to impose changes in
DUSP expression levels, we show that increased DUSP5 and
DUSP6 expressions are likely to be factors in the slow cycling
phenotype of SPSC through their effect on dephosphorylating
Erk1/2 whereas DUSP1 may instead primarily control other
functions  such  as  innate  immune  responses  to  stress  via
modulation of JNK1/2 activation.
METHODS
Cell systems: Human SV40 immortalized corneal epithelial
cells (svHCECs) were a generous gift from Dr. Araki Sasaki
(Ideta Eye Hospital, Kumamoto City, Kumamoto, Japan).
These cells were cultured in a 1:1 mix of Dulbecco’s modified
medium and Ham F12 (D/F12; Invitrogen, Carlsbad, CA)
complemented  with  10%  FBS  (Invitrogen)  and  5-ng/ml
epidermal  growth  factor  (EGF).  Expanded  fresh  human
corneal  epithelial  cells  (efHCECs)  were  isolated  by  the
following  procedure.  Three  explants  of  corneal  limbal-
peripheral  segments  dissected  from  unidentified  cadaver
corneas  provided  by  the  National  Disease  Research
Interchange (Philadelphia, PA) were cultured for 10 days in
SHEM  (a  95.0:  5.0:0.5  mix  of  D/F12,  FBS,  and  DMSO
complemented,  per  liter,  with  10  μg  each  of  insulin,
transferrin, and selenium, 10 ng cholera toxin, 5 ng EGF, and
28 mg phosphoethanolamine) and for 2 more days in EpiLife
(Invitrogen), a low calcium Boyce and Ham type formulation.
The outgrowths were trypsinized and expanded in culture for
12 generations in EpiLife before study. The corneal identity
of these cells was confirmed by showing that raising medium
calcium to 1 mM induced keratin 3 expression [19].
Lentivectors: Lentivectors for stable expression of shRNAmir
sequences against DUSP1, DUSP5, and JNK1 were generated
using  pGIPz  plasmids  clones  V3LHS_352110,
V2LHS_61931,  and  V3LHS_170502,  respectively  (Open
Biosystems,  Hunstville,  Al).  Blast  analysis  of  the  20-mer
antisense sequences expressed by these clones demonstrated
that in each case only the intended target RNA was a full
sequence match. The expression cassette incorporated into the
host cell DNA by these lentivectors drives the expression of
a turbo-GFP protein, the shRNAmir sequence and a puror gene
from  a  single  CMV  promoter.  Stable  overexpression  of
DUSP6 open reading frames (ORF) was accomplished using
lentivectors based on the pLEX plasmid (Open Biosystems).
The pLEX cassette drives expression of a MYC tagged ORF
and the puror gene.
Viral particles were generated by transducing HEK293T
cells cultured in 100 mm dishes with 2 μg active plasmid,
8 μg of packing plasmid mix (UMIX™, Rockville, Md.) in
10 ml medium (DMEM with 10% FBS) containing 20 μl
HEKFectin (BioRad, Richmond, CA). The culture medium
was  refreshed  after  overnight  incubation  and  virus-rich
supernatant was collected 48 h later after confirming that most
293 cells developed strong GFP fluorescence. The medium
was  then  exchanged  with  EpiLife  and  simultaneously
concentrated  sixfold  using  Amicon  Ultra  100,000  daltons
cutoff filters (Millipore, Billerica, MA). Transductions with
fractions of the purified vector suspensions were performed
in semi confluent 6-well dishes in EpiLife. Transduced cells
were  selected  with  puromycin  (15  μg/ml)  using  the
disappearance of all GFP negative cells and elimination of all
cells from an untransduced control culture as selection end
points.
To generate a control subline for non-specific effects of
shRNAs, we purchased viral particles incorporating a cassette
for the simultaneous expression of a non-coding shRNA and
puromycin resistance (Sigma, St Louis, Mo). After puromycin
selection, these cells were used to determine any potential
non-specific effect of the expression on cell properties, in
particular on the TKs.
Flow cytometry: Forward (FSC) and side (SSC) scatter flow
cytometry was used to determine any putative changes in the
relative  size  or  intracellular  complexity  of  the  cells,
respectively,  induced  by  the  expression  perturbation.  The
complete elimination of untransduced cells and degree of GFP
expression in the puromycin pGIPz transduced cells was also
determined by flow cytometry. Measurements were made in
an Accuri 6 (Ann Arbor, MI) flow cytometer.
Immunostaining:  Control  and  puromycin  selected  cells
transduced with the pLEX-DUSP6 ORF were immunostained
with a FITC-conjugated anti MYC tag antibody (Millipore).
Western blotting: Cultured cells were lysed, sonicated, and
spun  down.  The  supernatant  was  collected,  protein
concentration was measured with the BCA™ protein assay kit
(Thermo  Scientific,  Rockford,  Il)  and  identical  protein
amounts  were  electrophoresed  in  10-well  10%
polyacrylamide  gels,  electroblotted  to  nitrocellulose
membranes, and reacted with primary antibodies. After proper
washings, the membranes were reacted with the appropriate
HRP-conjugated antibody. HRP levels were determined by
chemilumiscence  using  ECL  (General  Electric,
Buckinghamshire, UK). Antibodies for Erk1/2, pErk1/2, were
purchased from Santa Cruz (Santa Cruz, CA); p38, p-p38,
JNK/SAP and p-JNK/SAP were from Cell Signaling, DUSP1
and DUSP5 were from Abnova (Walnut Creek, CA). Relative
HPR signal intensities were manually determined with the
histogram feature of Photoshop using in each case the signal
free proximal area to subtract a background value.
Tritriated  thymidine  uptake:  Triplicate  cultures  were
incubated at 37 °C for 2 h with 1 μCi/ml [3H]thymidine (3.3
to 4.8 TBq/mmol). They were then washed twice with cold
PBS, three times with ice-cold 5% trichloroacetic acid (TCA),
and twice with cold 90% alcohol. Cell lysis was obtained with
0.2 N NaOH/0.2% SDS. Radioactivity was measured in a Tri-
Carb 2900TR instrument (Perkin-Elmer, Boston, MA) and the
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with a BCA protein assay kit.
Growth curves: Twenty thousand control and subline cells
were seeded on 6-well plates and cultured for 96, 120, and 144
h. At the indicated times, duplicate cultures were trypsinized
using 950 μl enzyme and a 20 min incubation, to ensure
complete  cell-substratum  and  cell-cell  dissociation.  The
single cells suspensions were supplemented with 50 μl FBS,
and the amount of cells in 100 μl suspension, which in all cases
exceeded 10,000 cells, was accurately determined using the
cell counting facility of the Accuri instrument.
Gene expression of typical DUSPs in corneal epithelium and
svHCECs:  MAS  5  (Affymetrix,  Santa  Clara,  CA)  signal
intensities and present/absent status for 9 typical DUSPs were
obtained  from  the  Affymetrix  95  A  chip-based  gene
expression studies on intact human corneal epithelium from
cadaver donor corneas by Turner et al. [20]. The data are
available through the accession number GSE5543 at the NCBI
Gene  Expression  Omnibus  (GEO).  The  same  U95  A
microarray  has  been  used  to  characterize  global  gene
expression  in  stratified  epithelia  generated  using  the
svHCECs.  Briefly,  svHCECs  were  cultured  on  collagen-
coated  polyester  filters  (Transwell-Clear™;  Costar,
Cambridge, MA) in medium supplemented with 40 mg/ml
L(+)-ascorbic acid at the liquid–air interface [21]. Stratified
cultures with transepithelial resistance values greater than 400
ohm/cm2  were  dissolved  in  TriReagent™,  total  RNA  was
isolated, processed for microarray hybridization and results
were  extracted  from  the  raw  hybridization  images  using
MAS5, as described [20]. A complete description of all the
results  of  this  latter  study  besides  those  related  to  DUSP
expression, will be presented elsewhere.
TABLE 1. EXPRESSION OF TYPICAL DUSPS IN WHOLE CORNEAL EPITHELIUM DERIVED FROM FRESH TISSUE AND IN PSEUDO-EPITHELIUM GENERATED IN
CULTURE BY SVHCEC CELLS.
    DUSP
Sample Parameter 1 2 4 5 6 7 8 9 10 16
Tissue SI 7,091.6 30.3 17.9 325.1 394.9 46.7 35.1 33.2 84.1 NR
  P/A/M PPP AAA AAA PPP PPP PAA PAA PPA PPP  
svHCEC SI 5,512.4 150.1 235.9 392.8 138.8 11.7 19.2 36.8 129.2  
  P/A/M PPP PPA PPP PPP PPP AAA AAA PAM PPP  
         Signal intensities (SIs) represent the average of three independent triplicates in each case. The Present/Absent/Marginal MAS
         5 readings (P/A/M) for each triplicate are presented in concatenated format. NR, not represented in the array.
Figure  1.  Basic  features  of  svHCECs
transduced with various lentivectors. A-
H: Light scatter plots (A, C, E, and G)
and  histograms  of  GFP  fluorescence
(B, D, F, and H). A,B: control cells;
C,D:  DUSP1  shRNA  cells;  E,F:
DUSP5  shRNA;  G,H:  DUSP6  ORF.
I,J:  Control  cells  (I)  and  cells
transduced  with  the  MYC  tagged
DUSP6 ORF (J). In the control stain is
seen  exclusively  in  the  nucleus,
corresponding  to  the  location  of  myc
expression. In the transduced cells there
is  additional  stain  throughout  the
cytosol  including  strong  stain  in  the
perinuclear area. K: western blot of all
three terminal MAPKs and actin for the
control cells and cells transduced with
DUSP1, DUSP5, and non coding (NC)
shRNA and the MYC tagged DUSP6
ORF.
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The analysis of the microarray data for fresh tissue corneal
epithelium shows that of nine DUSPs represented in the array
(DUSP16 is not represented), only four, DUSP1, DUSP5,
DUSP6, and DUSP10 were appreciably expressed (Table 1).
The validity of the MAS5 SI readings for these DUSPs was
corroborated  by  real  time  PCR  in  human  conjunctival
epithelial cells [17]. The other five either had signal intensities
barely above background and/or partially or completely failed
the  present/absent  MAS  5  test.  Comparable  results  were
obtained in a similar U95A-based gene expression study using
the  svHCEC  cell  line  after  the  cells  had  undergone
stratification at an air water interface. The sv transformed cells
though had an additional moderate expression of DUSP2 and
DUSP4  (Table  1).  This  is  consistent  with  the  genomic
aberrations observed in these cells [22].
Figure  1  depicts  comparative  features  of  the  control
svHCEC  and  the  sublines  generated  by  lentiviral
transductions.  Flow  cytometry  showed  that  neither  the
forward  light  scatter  nor  the  side  light  scatter,  relative
measures  of  cell  size  and  granularity,  respectively,  were
affected by the combined expressions of GFP, shRNA and
puro’  induced  by  the  pGIPz  vector  (Figure  1A,C,E).  The
expression  of  DUSP6  caused  a  12%  increase  in  cellular
granularity.  The  GFP  levels  attained  with  the  pGIPz
lentivectors for DUSP1 and DUSP5, a direct measure of the
expression  of  the  shRNAmirs  were  comparable  (Figure
1D,F). Since the pLEX vector for DUSP6 expression does not
express a fluorescent protein (Figure 1H) the expression was
determined using an anti MYC tag antibody (Figure 1I,J). In
all cells, the tag was visible and concentrated in the perinuclear
(i.e., ribosomal) zone, suggesting active synthesis, and evenly
distributed throughout the cytosol. In addition, we determined
by western blotting that neither of the applied transductions
affected the levels of expression of the three TKs or of β-actin
(Figure 1K). Since the amount of actin per cell is usually
considered  invariant,  this  latter  result  implies  a  constant
amount of protein per cell.
Figure  2  summarizes  the  effects  of  the  lentivector-
induced  modification  of  DUSP  activity  on  the
phosphorylation levels of all three TKs in the svHCEC. Unless
indicated otherwise, cells were starved of growth factors by
incubating them for 24 h in base media (D/F12 for svHCECs,
complement-free EpiLife for the efHCECs using multiple
replicate cultures. Next, cells were reactivated by the addition
of either 10 ng/ml EGF in the case of the svHCEC or EpiLife
complement (contains bovine pituitary extract and insulin) in
the case of the efHCECs. Cultures were collected just before
reactivation  or  5,  15,  30,  and  60  min  thereafter.  For  the
DUSP1  shRNA  experiments,  the  five  control  and  five
transduced cell time points were run side by side, each with
MW markers. For the DUSP5 shRNA and the DUSP6 ORF,
to allow the side by side time course comparison to be present
in a single 10-well gel, we ran separately one gel for the 0–5
min time points and another for the 5–60 min comparisons.
In the untransduced svHCEC, addition of EGF caused a
rapid and dramatic increase in the phosphorylation status of
all  three  TK  families  within  5  to  15  min,  as  previously
described [23]. In all cases, this was followed within the next
60–90 min by a return toward substantially lower steady-state
levels (Figure 2A-C). These decreases coincide with rises in
DUSP1 and DUSP5 protein concentration. Cells transduced
with the non-coding shRNA showed identical responses (not
shown).
In the cells transduced with anti DUSP1 shRNAmir, the
increases in DUSP1 were essentially abolished and all three
TKs maintained high levels of activity throughout the first 60
min of post-EGF exposure. In the cells transduced with the
DUSP5 shRNAmir, the DUSP5 rise was nullified and Erk1/2
continuously  increased  over  this  period,  but  the
phosphorylation changes in the JNK/SAPK and p38 kinases
were  not  affected.  The  differences  in  phosphorylation  in
response to EGF between the cells transduced with shRNAs
for DUSP1 and DUSP5 are shown in Figure 3 in densitometric
plots of the results presented in Figure 2A,B.
DUSP6  overexpression  specifically  prevented  the
formation of any substantial levels of pErk1/2 (Figure 2C).
The EGF-induced phosphorylation of p38 and JNK1/2 did not
seem to be affected by DUSP6 overexpression; small effects
on  JNK1/2  were  observed  in  a  second  identical  test  (not
shown).
Next, we examined in a comparative manner the steady-
state levels of phosphorylation of all the TKs in cells not
subjected to the starvation and reactivation cycle. Inhibition
of either DUSP1 or DUSP5 by their respective shRNAmir
vectors  caused  similar,  moderate  increases  in  pErk1/2.  In
addition, the DUSP1 anti-sense selectively caused a strong
enhancement of pJNK1/2 formation (Figure 2D). Neither the
DUSP1 nor the DUSP5 shRNAs caused a substantial change
in p-p38 relative to control in this condition. Measurements
of DUSP1 expression before and 60 min after addition of EGF
showed that the DUSP5 shRNA did not interfere with the
control rise in DUSP1 described in Figure 1A-H (Figure 2F).
The  effects  of  changes  in  DUSP  expression  on  Erk1/2
phosphorylation were also determined in efHCECs that were
maintained in the low calcium ([Ca2+]=0.06 mM), serum-free
EpiLife medium to prevent differentiation [24]. Growth factor
deprivation followed by reintroduction of the EpiLife growth
factor supplement caused changes in Erk1/2 phosphorylation
similar to those observed with the svHCECs (Figure 2G).
Intriguingly, the comparison of 0 times for both svHCEC and
efHCEC suggested that the DUSP5 shRNA was uniquely able
to  increase  the  pErk1/2  levels  even  in  growth  factor-free
conditions (Figure 2B and Figure 2G).
Finally, we correlated the changes in TK phosphorylation
patterns with thymidine uptake and proliferation rates (Figure
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1699Figure 2. Effects of DUSP1, DUSP5,
and DUSP6 expression changes on the
steady-state  and  post  activation  time
course  of  terminal  kinase
phosphorylation  in  svHCEC  and
efHCECs  cells.  A:  Effect  of  DUSP1
shRNAmir.  The  antisense  agent
prevented  the  post  EGF  activation
increases  in  DUSP1  protein  and
concomitantly abolished or diminished
the decline in the initial EGF induced
phosphorylations  of  Erk1/2,  JNK1/2,
and  p38  normally  occurring  in  the
control. B. Effect of DUSP5 shRNAmir.
The antisense agent completely blocked
the  post-EGF  increase  in  DUSP5
protein  levels  and  abolished  the  post
peak  decline  in  pErk1/2
phosphorylation.  This  agent  did  not
visibly modify the time course of the
phosphorylation responses of JNK1/2 or
p38.  C.  Effects  of  overexpression  of
DUSP6. Phosphorylation of Erk1/2 in
response  to  EGF  was  virtually
abolished. The effects on the other two
terminal kinases were nil or minimal.
D.  Comparison  of  the  effects  of
shRNAmirs  against  DUSP1  and
DUSP5  expression  on  the
phosphorylation of the terminal kinases
in cells growing in log phase (50%–80%
confluent)  in  whole  culture  medium.
Both antisense interventions increased
pErk1/2  steady-state  levels.  DUSP1
selectively  increased  pJNK1/2
phosphorylation. Neither had an effect
on  p-p38  steady-state  expression.  E.
Effect  of  expression  of  JNK1
shRNAmir on the expression of JNK1
protein in svHCEC cells. F. Experiment
showing  that  the  permanent
transduction with DUSP5 shRNA does
not  interfere  with  the  rise  in  DUSP1
protein that occurs after cell reactivation
with  EGF.  G.  Effect  of  DUSP5
shRNAmir on pErk1/2 phosphorylation
in  the  efHCECs  cells.  Blots  A-E  are
representative of two or more repeats.
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17004). In both svHCEC (Figure 4A) and efHCEC (Figure 4B)
cultures,  DUSP5  shRNAmir  and  DUSP6  ectopic  gene
expression, respectively, augmented and depressed thymidine
uptake (p<0.01). The DUSP1 shRNAmir, in contrast, caused
a statistically significant small decrease in uptake rate in the
svHCEC  and  had  no  statistically  significant  effect  in  the
efHCEC. Growth curves for the svHCEC cells confirmed that
the  changes  in  thymidine  uptake  reflected  changes  in
proliferation rates (Figure 4C). The DUSP5 shRNA and the
DUSP6 ORF cell lines grew faster and slower, respectively,
than either the untransduced control or the DUSP1 shRNA
subline.  From  the  changes  in  cell  numbers  between  two
successive time points, we calculated doubling times of 26,
26, 21, and 45 h for the untransduced control, DUSP1 shRNA,
DUSP5 shRNA, and DUSP6 ORF cell lines, respectively.
The combined results of Figure 2 and Figure 4 for the
svHCEC cells demonstrated that while DUSP1 and DUSP5
knockdown  enhanced  Erk1/2  phosphorylation  to  similar
levels,  only  the  latter  caused  a  substantial  change  in
proliferation. Hence, since the immunoblots shown in Figure
2D indicated that the main difference between the effects of
DUSP1 and DUSP5 shRNAmirs were on the steady-state
levels of activated JNK1/2, we investigated if the changes in
these  enzyme  levels  could  be  a  factor  in  the  overall
proliferation rate; we found that drastic reduction of JNK1
expression  by  its  shRNAmir  lentivector  (Figure  2E)  was
sufficient to cause a substantial increase in proliferation rate
(Figure 4D).
DISCUSSION
SPSCs are in a slow cycling state in vivo [16] and display poor
clonogenic capacity [16,25]. We have proposed that this latter
feature reflects their inability to undergo rapid proliferation
when suddenly transferred from the in vivo to the artificial ex
vivo condition. In support of this notion, a) bone marrow SP
cells  similarly  fail  to  initiate  colonies  immediately  after
extraction, yet convert into highly clonogenic cells following
a period of organ culture in a semi in vivo environment [26]
and b) similarly change from low to high clonogenicity when
limbal segments were cultured in vitro for a week before
single limbal epithelial cell collection (unpublished).
Gene microarray studies of SP stem cells from pig limbus
[18] and human conjunctiva [17] and limbus (unpublished)
revealed several features that have the potential to underpin
this  slow  cycling  phenotype.  One  of  them  is  the  high
expression level of several DUSPs, relative to those of their
nonSP  counterparts.  DUSP5  is  the  most  prominently
overexpressed DUSP in the two published studies. It is 10.6
times higher in the human conjunctival SP cell [17] than in
the nonSP counterparts, 2.8 times better expressed in the pig
limbus  [18]  and  21  times  more  in  the  human  limbus
(unpublished), respectively. DUSP1 is also overexpressed in
these systems, but to a lesser extent. DUSP6 is overexpressed
in the human system, but not in the porcine cells. Additionally,
DUSP1 gene expression levels are intrinsically very high,
similar to those of housekeeping enzymes such as β-actin
(ACTB) or GAPDH [17]. These observations make it unlikely
that the other more weakly expressed DUSPs are significant
players in the regulation of MAPK dependent cell activities.
In this context, the current results demonstrate that, a) DUSP5
affects the phosphorylation state of Erk1/2 in the presence of
unmodified DUSP1 activity; b), sustained phosphorylation of
Erk1/2 induced by inhibition of DUSP5 activity is associated
with increased epithelial cell proliferation; and c) conversely,
prevention of Erk1/2 phosphorylation by DUSP6, causes a
major  decrease  in  proliferation  rates.  In  contrast  to  these
seemingly  straightforward  relationships  between  Erk1/2
phosphorylation  and  proliferation  rates,  no  measurable
change in proliferation rates were seen when the Erk1/2 levels
were augmented via DUSP1 shRNAmir vector, in either the
Figure  3.  Densitometric  plots  of  the
phosphorylated MAPK bands displayed
in Figure 2. A and D: p.p38. B and E:
pJNK1. C and E: pErk1. Top frames are
for DUSP1 shRNA, bottom frames for
DUSP5  shRNA.  The  values  were
normalized  respective  to  loading
controls, either total Erk or actin.
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1701sv or efHCEC systems. This latter result may be related to an
intrinsic anti-proliferative feature of activated JNK1/2 in these
cells, as suggested by the enhanced thymidine uptake rate
observed in the JNK1 deficient sub line (Figure 4D). Thus,
even though DUSP1 knockdown prolonged and enhanced
Erk1/2  phosphorylation,  its  concomitant  elevation  of
pJNK1/2 levels may nullify the pro-proliferative effect of
pErk1/2, suggesting the existence of set points for protein
concentrations,  affinities  and  activity  rates  intrinsically
calibrated  to  buffer  the  pro-proliferative  effect  of  Erk1/2
activation (Figure 5), as suggested by earlier studies [27]. We
cannot discount involvement of p38 in addition or instead of
JNK in such a putative regulatory MAPK cross stalk [28].
While we have not studied here the effect of the DUSP1
overexpression on responses observed in the ocular surface
SPSCs [17,18], concurrent declines in pJNK1/2 formation
may similarly provide a compensation whereby any negative
effect on proliferation caused by reduced pErk1/2 levels is
nullified by the enhancement caused by decreased pJNK1/2
(Figure  2B).  Additionally,  based  on  the  role  of  activated
JNK1/2 on cellular responses to a variety of stress stimuli or
pro-inflammatory cytokines, one would expect cells with high
constitutive levels of DUSP1 gene to be better protected than
untransduced cells from activation of intracellular pathways
leading to apoptosis [29,30] or abnormal differentiation [31].
Finally, the results suggest the physiologic significance
of  MAPKs-DUSPs  stoichiometry  on  functional  outcomes.
Knockdown of either DUSP5 or DUSP1 fostered higher levels
of Erk1/2 phosphorylation, even though the DUSP1 rise in
response to EGF was not unaltered. This suggests that the
absolute rate of Erk1/2 phosphorylation immediately after
addition  of  EGF  and  even  following  the  post-activation
induction of DUSP protein (Figure 1A-J) expression exceeds
the dephosphorylating capacity of each of these two enzymes
plus that of DUSP6 and any other phosphatase that may be
able  to  target  Erk1/2,  e.g.,  DUSP2  and  DUSP4,  the  two
additional  classical  nuclear  phosphatases  expressed  in  the
svHCECs.  Hence,  it  will  be  important  to  pursue  studies
Figure  4.  Relative  thymidine
incorporation and proliferation rates of
svHCEC and efHCECs transduced with
DUSP1 or 5 shRNAmirs or the DUSP6
ORF in the presence of 10 ng/ml EGF.
A: Effects of DUSP transductions on
svHCECs.  B:  Effects  of  DUSPs
transductions  efHCECs.  C:  Growth
curves for the control svHCEC and the
transduced  cell  lines.  D:  Effect  of
JNK1  shRNAmir  on  proliferation  of
svHCECs.  Thymidine  uptake  data
represents  the  mean±SEM  of  three
independent experiments. The asterisks
indicate p<0.01. Growth curves shown
are  for  a  single  experiment
representative  of  two  independent
measurements.  Bars  are  the  average
deviation  for  the  duplicates  in  the
experiment shown.
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1702examining whether the simultaneous overexpression of two
phosphatases,  as  observed  in  the  SPSC,  can  cause  larger
inhibitory effects than those observed in this study with single
DUSP6 overexpression.
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